- SEK15.67bn
- SEK17.95bn
- €425.00m
Brief: Vimian Q1 Adjusted EBITA EUR 24.1 Million
Brief: Vimian Group Rights Issue Oversubscribed
Brief: Vimian Announces New Financial Targets
Brief: Vimian Resolves On Rights Issue Of Up To SEK 1,633 Mln
Magnus Welander Proposed As New Chairman
Brief: Vimian Says Sees Potential Some M&A Talks
Brief: Vimian Q4 Adjusted EBITA EUR 22.6 Million
Brief: Vimian Appoints Patrik Eriksson As New CEO
Brief: Vimian Says Continues Efforts To Deliver Margin Expansion
Brief: Vimian Q3 Adjusted EBITA EUR 18.3 Million
Brief: Vimian Q2 Adjusted EBITA EUR 20.3 Million
Brief: Vimian Group CEO To Step Down At The End Of The Year
Brief: Vimian To Seek Compensation From Sellers Of Veterinary Orthopedic Implants
Brief: Vimian Q1 Revenue EUR 88.1 Million
Brief: Vimian Q1 Operating Profit Rises By Two Thirds
Brief: Vimian Resolves On Issue Of Shares To Sellers Of Kahu Vet Group
Brief: Vimian Unit and Fidelio Reach Settlement with DePuy Synthes
Brief: Vimian Says Subsidiary Reaches Settlement Agreement Resolving Patent Litigation With Depuy Synthes
Brief: Vimian Group Acquires Veterinary Services Platform In Australia